The Early Cancer Therapeutics Group at Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, offers hope for adults whose cancers haven’t responded to standard treatments through access to the most current phase I clinical trials available from Mayo Clinic researchers, pharmaceutical companies and the National Cancer Institute. People who have cancers that are treatment-resistant, drug-resistant or cancer-therapy-resistant can be seen by the Early Cancer Therapeutics Group. Mayo Clinic doctors are experts in accurately diagnosing cancer and getting you the right answers, the first time. Mayo Clinic is top-ranked in more specialties than any other hospital, according to U.S. News & World Report, and the Cancer Center continually ranks among the top hospitals in the U.S. for Cancer. Mayo Clinic Comprehensive Cancer Center is a National Cancer Institute (NCI)-designated comprehensive cancer center.